Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation

NCT: NCT07575269 · RECRUITING

NCT IDNCT07575269
StatusRECRUITING
Start Date2026-07-07
Completion2030-01-01
SponsorBoston Scientific Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

The goal of this clinical trial is to learn if the FARAFLEX™ Mapping and pulsed field ablation (PFA) System can safely and effectively treat symptomatic, drug-refractory Paroxysmal atrial fibrillation (PAF) and Persistent atrial fibrillation (PersAF). The main question it aims to answer is: Is the FARAFLEX Mapping and PFA System a safe and effective treatment for patients? Participants will undergo an ablation procedure using the FARAFLEX Mapping and PFA System.

Frequently Asked Questions

What is Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation?

Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation is a clinical trial registered under NCT07575269. Current status: RECRUITING.

What is the status of NCT07575269?

The current status of NCT07575269 (Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation) is: RECRUITING.

When did Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation start?

Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation started on 2026-07-07.

Related Devices

PMA P220032Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillationBoston Scientific Corporation PMA P020025catheter, percutaneous, cardiac ablation, for treatment of atrial flutterBoston Scientific PMA P150005catheter, percutaneous, cardiac ablation, for treatment of atrial flutterBoston Scientific Corp PMA P950001Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodesBoston Scientific PMA P960004Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodesBoston Scientific

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑